Cryo-Cell International (NYSEAMERICAN:CCEL) Shares Cross Above 50-Day Moving Average – Time to Sell?

Cryo-Cell International, Inc. (NYSEAMERICAN:CCEL) crossed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $0.00 and traded as high as $8.11. Cryo-Cell International shares last traded at $7.90, with a volume of 10,741 shares.

Cryo-Cell International Trading Down 0.8 %

The firm has a market capitalization of $63.15 million, a price-to-earnings ratio of -7.39 and a beta of 0.49.

Cryo-Cell International (NYSEAMERICAN:CCEL) last posted its quarterly earnings data on Tuesday, October 15th. The company reported $0.13 earnings per share for the quarter, topping the consensus estimate of $0.02 by $0.11. The company had revenue of $8.07 million during the quarter. Cryo-Cell International had a negative net margin of 28.03% and a negative return on equity of 42.06%.

Cryo-Cell International Announces Dividend

The company also recently disclosed a — dividend, which was paid on Friday, November 29th. Stockholders of record on Friday, November 15th were issued a dividend of $0.25 per share. The ex-dividend date of this dividend was Friday, November 15th. Cryo-Cell International’s payout ratio is -94.34%.

Institutional Trading of Cryo-Cell International

A hedge fund recently raised its stake in Cryo-Cell International stock. Geode Capital Management LLC raised its holdings in Cryo-Cell International, Inc. (NYSEAMERICAN:CCEL) by 68.5% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 39,860 shares of the company’s stock after acquiring an additional 16,203 shares during the quarter. Geode Capital Management LLC owned about 0.49% of Cryo-Cell International worth $254,000 as of its most recent SEC filing. 10.44% of the stock is currently owned by institutional investors and hedge funds.

About Cryo-Cell International

Cryo-Cell International, Inc engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, auto-immune diseases, multiple sclerosis, Alzheimer's disease, Parkinson's diseases.